Dr. Jiah Pearson-Leary is a seasoned biopharma consultant with a strong scientific background. As the CEO and Co-Founder of Spire Bioadvisors since September 2023, he drives inThought Research’s strategy arm, providing crucial support for biopharma leaders in determining and quantifying areas of portfolio opportunity. His experience includes portfolio strategy, business development, and product planning. Through inThought, he serves in fractional executive roles in client companies to fill critical gaps in expertise while clients are transitioning through key growth phases.
Prior to inThought, Dr. Pearson-Leary gained valuable industry experience at Fishawack Health, where he led strategic communications support for oncology programs and served as a scientific expert across therapeutic areas. This experience enhances his ability to provide commercial support and develop strategic communications for biopharma clients.
Dr. Pearson-Leary’s extensive bench research experience, including nearly 10 years at the Children’s Hospital of Philadelphia and the University of Pennsylvania, provides him with a critical perspective for evaluating the scientific potential of assets. This background makes him particularly adept at bridging the gap between scientific innovation and commercial strategy in his current roles.
